相关实验视频
Updated: May 8, 2025
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
31.6K
与眼科皮质类固醇相关的不良事件:FDA不良事件报告系统 (FAERS) 数据库的药监测研究
Chengzhi Liu1, Xinyu Wang1, Xusheng Cao1
1Beijing Tongren Eye Center, Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Frontiers in pharmacology
|December 26, 2024
概括
眼科皮质类固醇虽然对眼睛炎症有效,但会带来白内障和视力丧失等风险. 这项研究分析了不良事件,强调需要仔细监测患者以尽量减少风险.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 皮质类固醇在眼科中广泛用于治疗炎症疾病.
- 长时间或高剂量使用与不良药物反应 (ADRs) 相关,例如眼内压力升高和白内障.
- 目前还没有对眼科皮质类固醇副作用进行系统的比较.
研究的目的:
- 调查眼科皮质类固醇的安全性.
- 为了比较与常用的眼科皮质类固醇相关的不良药物反应 (ADRs).
- 使用FDA不良事件报告系统 (FAERS) 的药监数据进行分析.
主要方法:
- 来自FAERS数据库 (Q1 2004 - Q4 2023) 的ADR报告的回顾性分析.
- 对临床特征的分析,包括性别,年龄,施用途径和剂量形式.
- 应用信号检测方法 (ROR,PRR,BCPNN,MGPS) 来识别潜在的安全信号.
主要成果:
- 确定了9854个不良反应;Lotemax,Durezol和Ozurdex是最经常报告的.
- 女性占ADR的比例更高;大多数ADR发生在治疗早期.
- 常见的副作用包括白内障,眼睛炎症,视力障碍,脑膜炎和视网膜脱落. 对于Ozurdex,Iluvien和Triesence,人们注意到了产品问题.
结论:
- 眼科皮质类固醇的使用与严重的安全问题有关,特别是影响视觉功能的副作用.
- 仔细监测和个性化治疗对于减轻ADR风险至关重要.
- 建议将FAERS数据与临床研究结合起来进行进一步的研究,以深入了解这些安全问题.
相关概念视频
01:21Association Areas of the Cortex
4.5K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
4.5K
01:19Pharmacovigilance
732
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
732